نتائج البحث - Ratchanon Sophonmanee
- يعرض 1 - 8 نتائج من 8
-
1
-
2
Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases حسب Porntip Intapiboon, Parichat Uae-areewongsa, Jomkwan Ongarj, Ratchanon Sophonmanee, Purilap Seepathomnarong, Bunya Seeyankem, Smonrapat Surasombatpattana, Nawamin Pinpathomrat
الحاوية / القاعدة npj Vaccines (2022-11-01)احصل على النص الكامل
مقال -
3
Functional and phenotypic characterization of peripheral blood mononuclear cells from tuberculosis patients in Southern Thailand حسب Pyae Sone Oo, Jomkwan Ongarj, Ratchanon Sophonmanee, Narisa Mohthong, Sahasawat Suksan, Natapohn Saowaphong, Rachel Tanner, Nawamin Pinpathomrat
الحاوية / القاعدة Frontiers in Immunology (2025-10-01)احصل على النص الكامل
مقال -
4
Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study حسب Pimsiri Sripongpun, Nawamin Pinpathomrat, Ratchanon Sophonmanee, Jomkwan Ongarj, Purilap Seepathomnarong, Bunya Seeyankem, Naichaya Chamroonkul, Teerha Piratvisuth, Apichat Kaewdech
الحاوية / القاعدة Vaccines (2023-09-01)احصل على النص الكامل
مقال -
5
T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine حسب Ratchanon Sophonmanee, Jomkwan Ongarj, Bunya Seeyankem, Purilap Seepathomnarong, Porntip Intapiboon, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
الحاوية / القاعدة Vaccines (2022-09-01)احصل على النص الكامل
مقال -
6
Intradermal Fractional ChAdOx1 nCoV-19 Booster Vaccine Induces Memory T Cells: A Follow-Up Study حسب Ratchanon Sophonmanee, Perawas Preampruchcha, Jomkwan Ongarj, Bunya Seeyankem, Porntip Intapiboon, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
الحاوية / القاعدة Vaccines (2024-01-01)احصل على النص الكامل
مقال -
7
Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population حسب Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingviya, Pasuree Sangsupawanich, Sarunyou Chusri
الحاوية / القاعدة npj Vaccines (2022-05-01)احصل على النص الكامل
مقال -
8
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population حسب Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingviya, Pasuree Sangsupawanich, Sarunyou Chusri
الحاوية / القاعدة npj Vaccines (2022-09-01)احصل على النص الكامل
مقال
